Previous 10 | Next 10 |
The following slide deck was published by ClearPoint Neuro, Inc. in conjunction with this event. For further details see: ClearPoint Neuro (CLPT) Investor Presentation - Slideshow
ClearPoint Neuro's (NASDAQ:CLPT) stock rose ~18% after the company's Q1 results beat analysts' estimates and it raised lower-end of its FY22 revenue outlook a day ago. Net loss narrowed to -$3.96M, compared to -$2.54M in Q1 2021. GAAP EPS of -$0.17, beat estimates by $0.03. Total revenue...
ClearPoint Neuro, Inc. (CLPT) Q1 2022 Earnings Conference Call May 11, 2022 16:30 ET Company Participants Joe Burnett - President & Chief Executive Officer Danilo D’Alessandro - Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Capital Markets Marc W...
Image source: The Motley Fool. ClearPoint Neuro, Inc. (NASDAQ: CLPT) Q1 2022 Earnings Call May 11, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: ClearPoint Neuro, Inc. (CLPT) Q1 2022 Earnings Call Transcript
ClearPoint Neuro press release (NASDAQ:CLPT): Q1 GAAP EPS of -$0.17 beats by $0.03. Revenue of $5.03M (+24.8% Y/Y) beats by $0.85M. For further details see: ClearPoint Neuro GAAP EPS of -$0.17 beats by $0.03, revenue of $5.03M beats by $0.85M
SOLANA BEACH, Calif., May 11, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced financial results for its first quarter ended March 31,...
ClearPoint Neuro (NASDAQ:CLPT) Q1 consensus EPS estimate is -$0.20 and consensus revenue estimate is $4.18M (+3.7% Y/Y). CLPT is scheduled to announce Q1 earnings results on Wednesday, May 11, after market close. For further details see: ClearPoint Neuro Q1 2022 Earnings ...
ACOR, ADMA, APP, ASM, ASND, ASYS, ATCO, BAK, BMBL, BROS, BYND, CLPT, CLSD, CPA, CPNG, CYCC, DIS, DOX, ENVX, FLNC, FOSL, FSM, GAIN, GBDC, ICAD, KGC, LGO, LKCO, LTBR, MBII, METC, MFC, MQ, MRAM, MYO, NEON, NOAH, OCX, ONTX, OR, OTRK, PAAS, PAYS, PSTL, OTCPK:PWCDF, RIVN, SAND, SCM, SCTL, SLF, SMTS...
SOLANA BEACH, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced a collaboration with Higgs Boson Health (Durham, NC) to brin...
SOLANA BEACH, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it has received FDA clearance for version 1.1 of its ...
News, Short Squeeze, Breakout and More Instantly...
ClearPoint Neuro, Inc. Company Name:
CLPT Stock Symbol:
NASDAQ Market:
SOLANA BEACH, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced financial results for its first quarter ended Ma...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...
SOLANA BEACH, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene the...